BE857014R - Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens. - Google Patents

Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.

Info

Publication number
BE857014R
BE857014R BE179522A BE179522A BE857014R BE 857014 R BE857014 R BE 857014R BE 179522 A BE179522 A BE 179522A BE 179522 A BE179522 A BE 179522A BE 857014 R BE857014 R BE 857014R
Authority
BE
Belgium
Prior art keywords
preparation
nucleic acids
vaccines based
rna nucleic
acids associated
Prior art date
Application number
BE179522A
Other languages
English (en)
Inventor
L Dussourd D Hinterland
G Normier
A M Pinel
J Durand
Original Assignee
Fabre Sa Pierre
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fabre Sa Pierre filed Critical Fabre Sa Pierre
Application granted granted Critical
Publication of BE857014R publication Critical patent/BE857014R/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/025—Enterobacteriales, e.g. Enterobacter
    • A61K39/0266—Klebsiella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/05—Actinobacteria, e.g. Actinomyces, Streptomyces, Nocardia, Bifidobacterium, Gardnerella, Corynebacterium; Propionibacterium
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55572—Lipopolysaccharides; Lipid A; Monophosphoryl lipid A
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Mycology (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
BE179522A 1976-08-06 1977-07-20 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens. BE857014R (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR7624124A FR2360314A2 (fr) 1976-08-06 1976-08-06 Nouveaux vaccins perfectionnes a base de fractions ribosomales

Publications (1)

Publication Number Publication Date
BE857014R true BE857014R (fr) 1978-01-20

Family

ID=9176646

Family Applications (1)

Application Number Title Priority Date Filing Date
BE179522A BE857014R (fr) 1976-08-06 1977-07-20 Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.

Country Status (9)

Country Link
JP (1) JPS5320418A (fr)
AU (1) AU511331B2 (fr)
BE (1) BE857014R (fr)
CA (1) CA1087093A (fr)
DE (1) DE2735411C2 (fr)
ES (1) ES461415A2 (fr)
FR (1) FR2360314A2 (fr)
GB (1) GB1590144A (fr)
ZA (1) ZA774733B (fr)

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
WO2002053189A3 (fr) * 2001-01-06 2003-11-20 Benedikt Timmerman Complexe immunogene

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ191327A (en) * 1978-08-24 1981-07-13 W B Martin Pasteurellosis vaccine comprising antigenic material derived from the a1 and a2 serotypes of pasteurella haemolytica
JPS55106066U (fr) * 1979-01-19 1980-07-24
JPS639754Y2 (fr) * 1979-01-25 1988-03-23
FR2471785A1 (fr) * 1979-12-21 1981-06-26 Fabre Sa Pierre Preparations immunostimulantes a base d'arn ribosomaux et procede de preparation des arn
FR2475900A1 (fr) * 1980-02-20 1981-08-21 Fabre Sa Pierre Complexe vaccinal contenant un antigene specifique et vaccin le contenant
JPS58191628A (ja) * 1982-05-04 1983-11-08 Aisin Seiki Co Ltd 車輌ル−フパネル開閉装置
JPS626614A (ja) * 1985-07-03 1987-01-13 株式会社チノー 温室の天窓制御装置
JPS62104526A (ja) * 1985-10-30 1987-05-15 株式会社チノー 温室の制御装置
FR2596064B1 (fr) * 1986-03-18 1990-02-02 Pf Medicament Procedes industriels de fabrication de vaccins ribosomaux et vaccins ribosomaux obtenus
DE19703437A1 (de) * 1997-01-30 1998-08-06 Luitpold Pharma Gmbh Gemische äußerer Membranen und/oder Zellwände von Bakterien zur oralen Immunisierung gegen Schleimhautinfektionen

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS51142528A (en) * 1975-05-19 1976-12-08 Fabre Sa Pierre Production of vaccine based on antigenic libosome fractionation

Cited By (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4293545A (en) 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4328210A (en) 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4388299A (en) 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4506017A (en) * 1981-04-17 1985-03-19 Norden Laboratories, Inc. Modified Pasteurella haemolytica bacteria
US4559306A (en) * 1981-04-17 1985-12-17 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria
US4626430A (en) * 1981-04-17 1986-12-02 Norden Laboratories, Inc. Processes for growth of modified Pasteurella haemolytica bacteria and preparation of a vaccine therefrom
WO2002053189A3 (fr) * 2001-01-06 2003-11-20 Benedikt Timmerman Complexe immunogene

Also Published As

Publication number Publication date
ES461415A2 (es) 1978-07-16
GB1590144A (en) 1981-05-28
FR2360314A2 (fr) 1978-03-03
CA1087093A (fr) 1980-10-07
ZA774733B (en) 1978-07-26
JPS5320418A (en) 1978-02-24
AU511331B2 (en) 1980-08-14
DE2735411C2 (de) 1982-07-29
AU2753877A (en) 1979-02-08
FR2360314B2 (fr) 1980-04-25
DE2735411A1 (de) 1978-02-09

Similar Documents

Publication Publication Date Title
BE857014R (fr) Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.
DE3853027D1 (de) Zwei-Frequenzen NMR Oberflächenspule.
BE878430A (fr) Vaccins contre la pasteurellose
IT8020162A0 (it) Supporto per pazienti comprendente elementi di supporto mutualmente articolabili.
BE876245A (fr) Acides 5-thiazole-carboxyliques 2,4-disubstitues et leurs derives
BE873472A (fr) Procede d'epitaxie par faisceau moleculaire avec pre-melange
IT7921932A0 (it) Supporto elastico.
NL7804815A (nl) Bereiding van geconcentreerde bacteriecultures voor "direct-vat-set" kaasbereiding.
NL7804660A (nl) Verbeterde vaccins.
IT7924256A0 (it) Riscaldatore per acquario.
DE59006503D1 (de) Bodenbearbeitungsgerät.
BE839893A (fr) Preparation de vaccins a base d'acides nucleiques arn associes a des polysaccharides extraits de germes microbiens.
NO810853L (no) Magnetisk kontrollert legemiddel-infusjonssystem.
DE3851907D1 (de) Aliphatische Carboxamide.
BE858356A (fr) Derives d'acide 7-acylamino-8-oxo-3-oxa-1-azabicyclo-(4.2.0)octane-2-carboxylique, leur procede de preparation et leur application en therapeutique
FR2651505B1 (fr) Fragments d'acides nucleiques derives d'un genome de mycobacterie appropriee, leurs applications dans le diagnostic des infections a mycobacteries et plasmides contenant lesdits fragments.
BE857794A (fr) Vaccin contre la maladie de l'oedeme de porcelet
USD243540S (en) Aquarium
FR2313926A1 (fr) 4-phenyl-imidazolines substituees, leurs sels d'addition avec des acides et procedes pour leur preparation
Devrome The Metis: colonization, culture change and the Saskatchewan Rebellion of 1885
IT7821479A0 (it) Girante di soffiante, specialmente per soffiante per l'aria di combustione.
BE832268A (fr) Derives d'hydrazobenzene et leur preparation.
AU2611577A (en) Live influenza virus vaccine
GB1549890A (en) Soid cultivating implements
FR2352817A1 (fr) Acides 6'-amino-spiro(cycloalkane-1,2'-penam)-3'-carboxyliques

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: PF MEDICAMENT S.A.

Effective date: 19960322